These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7697692)

  • 41. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
    Bao YQ; Zhou J; Zhou M; Cheng YJ; Lu W; Pan XP; Tang JL; Lu HJ; Jia WP
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials.
    Cook W; Minervini G; Bryzinski B; Hirshberg B
    Postgrad Med; 2014 Oct; 126(6):19-32. PubMed ID: 25414932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
    Chakrabarti S; Sima AA
    Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma levels of glucose and lactate after intravenous glipizide administration in some insulin-dependent diabetics. Therapeutic effects of an associated glipizide-insulin treatment.
    Giampietro O; Navalesi R; Buzzigoli G; Boni C
    Curr Med Res Opin; 1979; 6(5):325-30. PubMed ID: 396109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus.
    Feinglos MN; Thacker CR; Lobaugh B; DeAtkine DD; McNeill DB; English JS; Bursey DL
    Diabetes Res Clin Pract; 1998 Mar; 39(3):193-9. PubMed ID: 9649951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus.
    Steffes MW; Sutherland DE; Goetz FC; Rich SS; Mauer SM
    N Engl J Med; 1985 May; 312(20):1282-7. PubMed ID: 4039409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.
    Nauck MA; Meininger G; Sheng D; Terranella L; Stein PP;
    Diabetes Obes Metab; 2007 Mar; 9(2):194-205. PubMed ID: 17300595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
    Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
    J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial.
    Abraira C; McGuire DK
    Am Heart J; 1999 Nov; 138(5 Pt 1):S360-5. PubMed ID: 10539798
    [No Abstract]   [Full Text] [Related]  

  • 52. Minimization of the Risk of Diabetic Microangiopathy in Rats by Nigella sativa.
    Somboonwong J; Yusuksawad M; Keelawat S; Thongruay S; Poumsuk U
    Pharmacogn Mag; 2016 May; 12(Suppl 2):S175-80. PubMed ID: 27279704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the BB/W-rat.
    Chakrabarti S; Cherian PV; Sima AA
    Diabetes Res Clin Pract; 1993 May; 20(2):123-8. PubMed ID: 8375264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.
    Del Prato S; Nauck M; Durán-Garcia S; Maffei L; Rohwedder K; Theuerkauf A; Parikh S
    Diabetes Obes Metab; 2015 Jun; 17(6):581-590. PubMed ID: 25735400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic effects of combination glipizide and human proinsulin treatment in NIDDM.
    Pasmantier R; Chaiken RL; Hirsch SR; Lebovitz HE
    Diabetes Care; 1990 Aug; 13 Suppl 3():42-6. PubMed ID: 2209343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Muscle magnesium and capillary basement membrane thickness in diabetes mellitus.
    Dyckner T; Hägg E; Lithner F; Nyhlin H; Wester PO
    Diabete Metab; 1988; 14(5):619-22. PubMed ID: 3234585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.
    Osei K; Rhinesmith S; Gaillard T; Schuster D
    Metabolism; 2004 Apr; 53(4):414-22. PubMed ID: 15045685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Muscle capillary basement membrane in identical twins discordant for insulin-dependent diabetes.
    Barnett AH; Spiliopoulos AJ; Pyke DA; Stubbs WA; Rowold E; Hoffmann P; Faller A; Kilo C; Miller JP; Williamson JR
    Diabetes; 1983 Jun; 32(6):557-60. PubMed ID: 6685074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.